* Tenon Medical Inc TNON.OQ TNON.O is expected to show a
rise
in quarterly revenue when it reports results on November 13 for
the period ending September 30 2024
* The Los Gatos California-based company is expected to
report a
26.1% increase in revenue to $1.19 million from $944 thousand a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for Tenon Medical Inc is for
a
loss of $4.23 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Tenon
Medical Inc
is 22.00, above its last closing price of $3.46.
This summary was machine generated November 12 at 03:52 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)